The anti-melanoma impact of diosgenin appeared to be dependent more on immunity against tumors than on direct tumor suppressive activity, as demonstrated by the tumor tissues' clear production of IFN-γ and CD4+/CD8+ T-cell infiltration. The gene discussed is CD8A; the disease is neoplasm.